Observational Study “orale + andere Antikoagulanzien”

Observed Drugs

Title of the Observational Study

ABW: TRI08888, (GARFIELD) Global Anticoagulant Registry in the Field, Prospective, multi centre, international registry of male and female patients newly diagnosed with atrial fibrillation.

Registered on
06/03/2010
Start date
06/04/2010
End date
06/03/2016
Executing company
Parexel International GmbH
Sponsor
Thrombosis Research Institute (UK)
Number of Docs1
n/a
Number of Patients2
50000
Payment per Patient3
300.00 €
Fee details
Pfund Sterling (GBP) pro retrospektivem Patient, 440 (GBP) pro prospektivem Patienten in einem Zeitraum von insg. 2 Jahren

Background

Independent journalism needs independent funding

Others can write stories. We want to reveal. We are the first investigative newsroom in Germany, which is independent, ad-free, and non-profit.

For us, the core of journalism means uncovering injustice and shortcomings in society. That’s why we investigate corruption in the health system, politicians abusing their power, and an elite that believes that rules are for the others.

To do our job, we need people, who support us. We ask you, too, to become a member and enable the work of 16 investigative journalists at CORRECTIV.

We are convinced that without independent and critical media, democracy fought for and won by our ancestors, cannot survive for long.